Amgen, Cytokinetics and Servier Announce Topline Results From GALACTIC-HF, a Phase 3 Trial of Omecamtiv Mecarbil in Patients With Heart Failure


You May Also Like

APHL Announces Newborn Screening Funding Recipients

Silver Spring, MD, Dec. 19, 2017 (GLOBE NEWSWIRE) -- For Immediate Release The Association of ...

Zenith Capital Closes $5.7 Million Private Placement

This press release is not for dissemination in the United States or through US ...